Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Carrier prodrugs bioavailability improvements

In other studies, bisphosphonate-pamidronate or alendronate were linked to the terminal carboxylic acid of the stabilized dipeptide Pro-Phe to improve the bioavailability of bisphosphonates by hPepTl-mediated absorption. In-situ single-pass perfused rat intestine studies revealed competitive inhibition of transport by Pro-Phe, suggesting carrier-mediated transport. Oral administration of the dipeptidyl prodrugs resulted in a 3-fold increase in drug absorption following oral administration to rats. The authors suggested that oral bioavailability of bisphosphonates may be improved by PepTl-mediated absorption when administered as peptidyl prodrugs [53]. Future mechanistic studies may prove if hPepTl is involved in the absorption process. [Pg.538]


See other pages where Carrier prodrugs bioavailability improvements is mentioned: [Pg.552]    [Pg.536]    [Pg.269]    [Pg.260]    [Pg.345]    [Pg.486]    [Pg.90]    [Pg.668]    [Pg.1709]   
See also in sourсe #XX -- [ Pg.7 , Pg.724 ]

See also in sourсe #XX -- [ Pg.7 , Pg.724 ]




SEARCH



Bioavailability carrier prodrugs

Bioavailability improvement

Bioavailability improving

Carrier prodrugs

Prodrug

© 2024 chempedia.info